Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
CN¥24.35 - CN¥42.99
Next Earnings Date
May 20 2025 (Estimate)
Next Earnings Date
May 20 2025 (Est.)
Latest price
Market Cap | CN¥13.01B |
EV | CN¥11.96B |
Shares Outstanding | 459.28M |
Beta | 0.91 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | CN¥33.94 |
P/E 2024E | 40.33x |
P/Revenue 2024E | 1.68x |
Revenue | 1.20% |
EPS | -25.00% |
Operating Cash Flow | -6.90% |
Free Cash Flow | -1.20% |
Revenue | 4.40% |
EPS | 13.00% |
Operating Cash Flow | 4.20% |
Free Cash Flow | 27.70% |
Gross Margin 2024E | 35.99% |
Net Profit Margin 2024E | 3.10% |
ROE 2024E | 3.64% |
ROCE 2023 | 7.57% |
DPS 2024E | CN¥0.26 |
Payout Ratio 2024E | 37.14% |
Div. Yield 2024E | 0.92% |
DPS Last 3Y CAGR | 38.80% |
Price
%
1M
3M
6M
1Y
3Y
5Y
Guangzhou Kingmed Diagnostics Group Co., Ltd.
603882
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Liang, Yaoming
Employees
11,586
Website
www.kingmed.com.cnIPO Date
2017-09-08
Headquarters
No. 10, Spiral 3rd Road, International Biological Island, Guangzhou, Guangdong Province, 510000, China
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved